Hemostasis and Tissue Sealing Agents Market

1. According to Transparency Market Research’s latest report on the global hemostasis and tissue sealing agents market for the historical period 2017– 2018 and forecast period 2019–2027, rise in demand for minimally invasive procedures and increase in global geriatric population are projected to drive the global hemostasis and tissue sealing agents market during the forecast period According to the report, the global hemostasis and tissue sealing agents market was valued at US$ 5.1 Bn in 2018 and is anticipated to expand at a CAGR of 8.3% from 2019 to 2027 Report Overview:https://www.transparencymarketresearch.com/hemostasis- tissue-sealing-agents-market.html Rise in demand for minimally invasive procedures: Key Drivers The preference for minimally invasive surgeries has increased significantly in the past few years. Minimally invasive surgeries have advantages such as shorter hospital stay, minimal incision, fewer post-surgical complications and shorter recovery time. Systemic hemostatic agents such as gelatin and collagen-based hemostat powders are widely used in minimally invasive procedures. These agents enable surgeons to perform complex surgeries. According to a study conducted by the World Health Organization (WHO), approximately 234.2 million major surgical procedures are undertaken by various hospitals and surgical centers across the world each year. Thus, rising number of surgical procedures and growing preference for minimally invasive procedures boosts the demand of hemostat and tissue sealing agents. Aging population increases the number of surgeries needing hemostat products boost market growth Treatment services have become affordable due to improvement in health care policies in countries such as the U.S., Japan, the U.K. and China. This, in turn, has increased the life expectancy of the population. Consequently, rise in the geriatric population increases the number of surgical procedures that use adhesion barrier and hemostat products. According to the U.S. Department of Health & Human Product estimates, the U.S. will have about 72.1 Mn geriatric population by 2030, which is more than twice the number in 2000. The UN Population Division has projected that the number of people aged 60 years and above will increase significantly during 2015–2030. In developed countries, the total proportion of people aged 60 years and above has increased from 12% in 1950 to 22% in 2011 and is expected to reach 32% by 2050. Thus, the aging population drives the uptake of hemostat, tissue sealant and adhesion barrier products and boosts market growth.

2. Request Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40 18 High cost and strict regulatory requirement to Hamper Market Hemostat and tissue sealant products development is a complex and expensive process. Regulatory approval of hemostat products demands valid scientific evidences, well controlled investigations and documented case studies. Despite high expense incurred for the development of hemostat products by manufacturers, the success rate of the approval of these products by regulatory bodies is low. Low efficacy and safety of the products have been attributed to the low approval rate of hemostat products. Only a small number of companies have entered the market due to setbacks faced in clinical studies by hemostat manufacturers. This hampers the growth of the hemostasis and tissue sealing agents market. Global Hemostasis and tissue sealing agents Market: Competitive Landscape This report profiles major players in the global hemostasis and tissue sealing agents market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments The global Hemostasis and tissue sealing agents market is highly fragmented, with the presence of a number of international as well as regional players Leading players operating in the global Hemostasis and tissue sealing agents market are oAdvanced Medical Solutions Group plc oBaxter oCohera Medical, Inc. oCryoLife, Inc. oC.R. Bard, Inc. oJohnson & Johnson Services, Inc. oIntegra LifeSciences Corporation oPfizer, Inc. oCohesion Technologies Inc. oB Braun Medical Inc oother prominent players. Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag= EB&rep_id=4018 About Transparency Market Research Transparency Market Research registered at Wilmington, Delaware, United States, is a global market research company providing custom research and consulting services. TMR provides in-depth insights into

3. factors governing demand in the market. It divulges opportunities across various segments based on Source, Application, Sales Channel, and End-Use that will favor growth in the market over the next 9 years. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ Contact Rohit Bhisey Transparency Market Research Inc. CORPORATE HEADQUARTER DOWNTOWN, 1000 N. West Street, Suite 1200, Wilmington, Delaware 19801 USA Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com Blog: https://tmrblog.com Email:sales@transparencymarketresearch.com